RadNet (NASDAQ:RDNT – Get Free Report) and Elanco Animal Health (NYSE:ELAN – Get Free Report) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations and dividends.
Insider and Institutional Ownership
77.9% of RadNet shares are owned by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are owned by institutional investors. 5.6% of RadNet shares are owned by company insiders. Comparatively, 0.9% of Elanco Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Volatility & Risk
RadNet has a beta of 1.54, indicating that its share price is 54% more volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.62, indicating that its share price is 62% more volatile than the S&P 500.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| RadNet | 0 | 1 | 4 | 3 | 3.25 |
| Elanco Animal Health | 0 | 3 | 5 | 1 | 2.78 |
RadNet currently has a consensus target price of $76.80, indicating a potential upside of 2.81%. Elanco Animal Health has a consensus target price of $18.33, indicating a potential downside of 6.58%. Given RadNet’s stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than Elanco Animal Health.
Profitability
This table compares RadNet and Elanco Animal Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| RadNet | -0.78% | 2.41% | 0.82% |
| Elanco Animal Health | 9.68% | 7.04% | 3.45% |
Valuation & Earnings
This table compares RadNet and Elanco Animal Health”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| RadNet | $1.91 billion | 3.01 | $2.79 million | ($0.20) | -373.50 |
| Elanco Animal Health | $4.44 billion | 2.20 | $338.00 million | $0.86 | 22.82 |
Elanco Animal Health has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.
Summary
Elanco Animal Health beats RadNet on 10 of the 15 factors compared between the two stocks.
About RadNet
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
About Elanco Animal Health
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.
